Sunan samfur:Palmitoylethanolamide
Sauran Sunaye:Hydroxyethyl palmitamide,N-Palmitoylethanolamine,Palmidrol
Matsakaicin: 99%
Lambar CAS:544-31-0
Nauyin Kwayoyin Halitta: 299.5
Tsarin kwayoyin halitta: C18H37NO2
Bayyanar: White Fine foda,PEA Mrico,PEA Granule
Girman Barbashi: 100% wuce raga 80
Matsayin GMO: GMO Kyauta
Shiryawa: a cikin 25kgs fiber ganguna
Adana: Ajiye akwati a buɗe a wuri mai sanyi, busasshiyar wuri, Nisantar haske mai ƙarfi
Rayuwar Shelf: watanni 24 daga ranar samarwa
Palmitoylethanolamide (PEA) Kari: Halitta Anti-Inflammatory & Neuropathic Pain Support
Gabatarwa
Palmitoylethanolamide (PEA) wani fatty acid amide ne na halitta wanda aka samar a cikin jiki kuma ana samun shi a cikin abinci kamar qwai, waken soya, da alayyafo. Ya sami kulawa don maganin kumburi, analgesic, da abubuwan neuroprotective, wanda ke goyan bayan bincike na asali da na asibiti. An tsara wannan ƙarin don tallafawa kula da ciwo na kullum, yanayin neuropathic, da kuma amsawar kumburi, bin ka'idoji masu kyau tare da takaddun shaida kamar GMP.
Mahimman Fa'idodi & Hanyoyin Aiki
- Maganin Ciwo & Ciwo
- PEA yana daidaita kumburi ta hanyar yin hulɗa tare da alpha mai haɓaka mai haɓaka mai haɓaka mai haɓakawa (PPAR-α) da masu karɓa na GPR55, rage cytokines mai kumburi da haɓakar mast cell.
- Nazarin asibiti yana nuna inganci a cikin yanayi kamar sciatica, rashin ciwo na tiyata na baya, da ciwon hanji mai ban tsoro, tare da rage jin zafi.
- Kariyar Neuro & Taimakon Hali
- PEA yana haɓaka siginar endocannabinoid (misali, haɓaka matakan 2-AG) kuma yana haɓaka macrophage efferocytosis, yana taimakawa gyaran jijiyoyi da ƙudurin neuroinflammation.
- Gwajin da bazuwar ya nuna babban ci gaba a cikin alamun manic (an kimanta ta hanyar YMRS) idan aka kwatanta da placebo, yana nuna yuwuwar tasirin yanayi.
- Tsaro & Haƙuri
- PEA yana da haƙuri tare da ƙarancin sakamako masu illa (misali, ƙaramin dizziness a cikin <20% na masu amfani) . An rarraba shi azaman kari na abinci a Turai (allunan 300-600 MG) da Amurka, wanda ya dace da amfani na dogon lokaci.
Ƙayyadaddun samfur
- Formulations: Capsules (400 MG), foda, da creams don amfani na baka/na waje.
- Shawarar da aka ba da shawarar: 300-1200 MG kowace rana, zuwa kashi 2-3. Tuntuɓi ma'aikacin kiwon lafiya don keɓaɓɓen jagora.
- Adana: Adana a cikin kwantena da aka rufe a -20°C (foda) ko -80°C (fuskoki masu narkewa) don kiyaye kwanciyar hankali.
Babban Shaidar Clinical
- Jin zafi na yau da kullun: Binciken meta-bincike na marasa lafiya na 1,294 ya nuna PEA ya rage rage yawan zafi a cikin yanayin neuropathic da kumburi.
- Atherosclerosis: Nazarin Dabbobi sun bayyana PEA attenuates plaque samuwar ta inganta anti-mai kumburi macrophage phenotypes.
- Lafiyar Ocular: Inganta aikin endothelial a cikin marasa lafiya masu hauhawar jini, yana ba da shawarar tasirin kariya na jijiyoyin jini.
Tsaro & Kariya
- Contraindications: Guji a cikin ciki / shayarwa da kuma rashin lafiyar kwai (saboda yuwuwar ƙirar kwai).
- Ma'amalar Drug: Babu wani muhimmin hulɗa da aka ruwaito, amma tuntuɓi likita idan kuna amfani da immunosuppressants ko NSAIDs.
Bayanin oda
- Marufi: Akwai a cikin zaɓuɓɓukan 10 MG zuwa 500 MG, tare da rangwamen kuɗi don bincike ko amfani da asibiti.
- Jirgin Ruwa na Duniya: Ana aikawa daga shagunan Amurka, EU, ko China a cikin kwanakin kasuwanci 1-8.
Me yasa Zabi PEA ɗin mu?
- Tsafta: ≥98% tsafta wanda GC/HPLC ya tabbatar.
- Bincike-Bayani: Tallafin sama da 50 binciken da aka yi bita na tsara, gami da gwaje-gwajen da aka buga a cikiCiwokumaJaridar British Journal of Pharmacology.
- Tabbacin Abokin Ciniki: Ofishin Better Business (BBB) ya amince da shi tare da tallafin ƙwararrun 24/7
